Veru's experimental drug helps older obese patients on Wegovy …
Jan 27, 2025 · Veru said on Monday its experimental drug in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting …
Veru says its drug preserved lean mass in patients taking Wegovy
Jan 27, 2025 · In a Phase 2b trial, older patients taking Novo Nordisk’s Wegovy and Veru’s experimental drug, called enobosarm, lost on average 1.2% of lean mass after 16 weeks, …
Veru Announces Positive Topline Data from Phase 2b QUALITY …
-- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects…...
Veru's drug retains muscle mass for older patients taking Wegovy
Jan 27, 2025 · The Miami-based company has been testing two doses of its oral selective androgen receptor modulator enobosarm in a phase 2b trial of 168 patients aged over 60 …
Veru's drug helps older Wegovy patients preserve muscle in …
(Reuters) -Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the …
Veru Announces Positive Topline Data from Phase 2b QUALITY
Jan 27, 2025 · In the topline efficacy analysis, the Phase 2b QUALITY clinical study met its primary endpoint with a statistically significant benefit in preservation of total lean body mass …
Muscle-building drug improves body composition in obesity trial, Veru …
Jan 27, 2025 · Trial volunteers taking Wegovy with Veru’s drug, called enobosarm, lost on average 1.2% of their lean body mass, compared with 4.1% in the Wegovy-only group. The …
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy…
Jan 27, 2025 · Veru Inc. on Monday unveiled topline data from its Phase IIb QUALITY study, demonstrating that its investigational selective androgen receptor modulator enobosarm can …
Veru Inc. Reports Positive Topline Results from Phase 2b ... - Nasdaq
Jan 27, 2025 · Veru Inc. announced positive topline results from its Phase 2b QUALITY clinical study, which evaluated the efficacy of enobosarm in preserving lean mass and improving body …
Veru Enrolls First Patients in Phase 2b Clinical Trial of
Apr 30, 2024 · The Phase 2b, multicenter, double-blind, placebo-controlled, randomized, dose-finding clinical trial was designed to evaluate the safety and efficacy of enobosarm 3mg, …
- Some results have been removed